Accurate immune cell analysis is essential for advancing cancer screening, immunotherapy monitoring and transplant safety. However, traditional methods and manual assays remain slow, labour-intensive, costly, and prone to variability, limiting their ability to deliver timely and reliable insights.
Conventional assays struggle with sensitivity, scalability, and reproducibility.
Monitoring the number and activity of NK cells is emerging as a critical biomarker for cancer, immune therapy efficacy, and immune system health.
An AI-powered platform utilizes innovative and proprietary single-cell analysis technology to allow for:
Rapid Immune Monitoring – Machine learning algorithms deliver precise NK cell counting and activity assessment within minutes.
Clinical Versatility – Supports early multi-cancer detection, NK cell therapeutic efficacy tracking, transplant compatibility evaluation, and environmental toxicity screening.
Enhanced Efficiency – Reduces time, cost, and variability compared to conventional methods, while improving usability and scalability across clinical and research settings.
By integrating AI, imaging, and cellular functional analysis, this platform aims to drive a new standard for immune monitoring and cellular diagnostics.
VentureBlick is involved in a preliminary study to help the company ascertain its potential in the global markets.
Selected advisors will not be identified individually – only their country and specialty will be made known. In addition, the report will be proprietary, and exclusively available only to the client.
ADVISORS NEEDED
· 10 advisors globally, across India, USA, Australia, China, Southeast Asia (Indonesia, Singapore, Malaysia, Thailand, Vietnam)
· Medical Advisor Specialties: Immunology, Oncology, Laboratory Medicine, Primary Care
Advisors should have at least 10 years of experience in their respective fields.
WORK REQUIRED
· Review: Read a detailed backgrounder on the company and its activities (1 hour)
· Complete a short survey to provide your expert insights and evaluation
NOTE
If your expertise aligns with this project, we encourage you to apply for consideration. Due to expected high interest, only shortlisted advisors will be contacted for follow-ups.
For specific questions regarding eligibility or other inquiries, please reach out via the contact details below.